At this time, a generic version of Natazia is not available in the United States. The manufacturer holds the exclusive rights to manufacture the contraceptive pill until 2016. When the patent expires, other drug companies may be able to make and sell generic Natazia. However, other patents for specific uses of Natazia or lawsuits may delay the release of a generic version.
Can I Buy Generic Natazia?
Natazia® (dienogest/estradiol valerate) is a prescription contraceptive product used to prevent pregnancy and to decrease heavy menstrual bleeding. It is one of the many oral contraceptives (birth control pills) available. It is the first four-phasic birth control pill (with four different levels of hormones throughout each pack), and is the first birth control pill that contains dienogest and estradiol valerate.
Natazia is made by Bayer HealthCare Pharmaceuticals, Inc. It is currently under the protection of patents that prevent any generic Natazia from being manufactured in the United States.
When Will Generic Natazia Be Available?
The first patent for Natazia currently expires in October 2016. This is the earliest predictable date that a generic version could become available. However, there are other circumstances that could come up to extend the exclusivity period of Natazia beyond October 2016. This could include such things as lawsuits or other patents for specific Natazia uses or lawsuits.
Once Natazia goes off-patent, there may be several companies that will begin manufacturing generic Natazia products.
Does Insurance Cover Natazia?
Each insurance company is different. There has been a long history of insurance companies not covering contraceptive products, although this is beginning to change. More and more insurance providers are beginning to cover contraceptives.
Because Natazia is not available in a generic form, you may have to pay a higher copayment, although coverage and copayments vary widely.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed July 4, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click